This report contains market size and forecasts of Influenza Vaccination in Global, including the following market information:
Global Influenza Vaccination Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Influenza Vaccination market was valued at 3603 million in 2020 and is projected to reach US$ 4308.7 million by 2027, at a CAGR of 4.6% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Influenza Vaccination companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza Vaccination Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Influenza Vaccination Market Segment Percentages, By Type, 2020 (%)
Egg Based
Cell Culture
Recombinant
China Influenza Vaccination Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Influenza Vaccination Market Segment Percentages, By Application, 2020 (%)
Hospitals
Research Organizations
Global Influenza Vaccination Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Influenza Vaccination Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Influenza Vaccination Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Influenza Vaccination Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Influenza Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Influenza Vaccination Overall Market Size
2.1 Global Influenza Vaccination Market Size: 2021 VS 2027
2.2 Global Influenza Vaccination Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Influenza Vaccination Players in Global Market
3.2 Top Global Influenza Vaccination Companies Ranked by Revenue
3.3 Global Influenza Vaccination Revenue by Companies
3.4 Top 3 and Top 5 Influenza Vaccination Companies in Global Market, by Revenue in 2020
3.5 Global Companies Influenza Vaccination Product Type
3.6 Tier 1, Tier 2 and Tier 3 Influenza Vaccination Players in Global Market
3.6.1 List of Global Tier 1 Influenza Vaccination Companies
3.6.2 List of Global Tier 2 and Tier 3 Influenza Vaccination Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Influenza Vaccination Market Size Markets, 2021 & 2027
4.1.2 Egg Based
4.1.3 Cell Culture
4.1.4 Recombinant
4.2 By Type - Global Influenza Vaccination Revenue & Forecasts
4.2.1 By Type - Global Influenza Vaccination Revenue, 2016-2021
4.2.2 By Type - Global Influenza Vaccination Revenue, 2022-2027
4.2.3 By Type - Global Influenza Vaccination Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Influenza Vaccination Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Research Organizations
5.2 By Application - Global Influenza Vaccination Revenue & Forecasts
5.2.1 By Application - Global Influenza Vaccination Revenue, 2016-2021
5.2.2 By Application - Global Influenza Vaccination Revenue, 2022-2027
5.2.3 By Application - Global Influenza Vaccination Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Influenza Vaccination Market Size, 2021 & 2027
6.2 By Region - Global Influenza Vaccination Revenue & Forecasts
6.2.1 By Region - Global Influenza Vaccination Revenue, 2016-2021
6.2.2 By Region - Global Influenza Vaccination Revenue, 2022-2027
6.2.3 By Region - Global Influenza Vaccination Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Influenza Vaccination Revenue, 2016-2027
6.3.2 US Influenza Vaccination Market Size, 2016-2027
6.3.3 Canada Influenza Vaccination Market Size, 2016-2027
6.3.4 Mexico Influenza Vaccination Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Influenza Vaccination Revenue, 2016-2027
6.4.2 Germany Influenza Vaccination Market Size, 2016-2027
6.4.3 France Influenza Vaccination Market Size, 2016-2027
6.4.4 U.K. Influenza Vaccination Market Size, 2016-2027
6.4.5 Italy Influenza Vaccination Market Size, 2016-2027
6.4.6 Russia Influenza Vaccination Market Size, 2016-2027
6.4.7 Nordic Countries Influenza Vaccination Market Size, 2016-2027
6.4.8 Benelux Influenza Vaccination Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Influenza Vaccination Revenue, 2016-2027
6.5.2 China Influenza Vaccination Market Size, 2016-2027
6.5.3 Japan Influenza Vaccination Market Size, 2016-2027
6.5.4 South Korea Influenza Vaccination Market Size, 2016-2027
6.5.5 Southeast Asia Influenza Vaccination Market Size, 2016-2027
6.5.6 India Influenza Vaccination Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Influenza Vaccination Revenue, 2016-2027
6.6.2 Brazil Influenza Vaccination Market Size, 2016-2027
6.6.3 Argentina Influenza Vaccination Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Influenza Vaccination Revenue, 2016-2027
6.7.2 Turkey Influenza Vaccination Market Size, 2016-2027
6.7.3 Israel Influenza Vaccination Market Size, 2016-2027
6.7.4 Saudi Arabia Influenza Vaccination Market Size, 2016-2027
6.7.5 UAE Influenza Vaccination Market Size, 2016-2027
7 Players Profiles
7.1 Abbott (U.S.)
7.1.1 Abbott (U.S.) Corporate Summary
7.1.2 Abbott (U.S.) Business Overview
7.1.3 Abbott (U.S.) Influenza Vaccination Major Product Offerings
7.1.4 Abbott (U.S.) Influenza Vaccination Revenue in Global (2016-2021)
7.1.5 Abbott (U.S.) Key News
7.2 AstraZeneca (Europe)
7.2.1 AstraZeneca (Europe) Corporate Summary
7.2.2 AstraZeneca (Europe) Business Overview
7.2.3 AstraZeneca (Europe) Influenza Vaccination Major Product Offerings
7.2.4 AstraZeneca (Europe) Influenza Vaccination Revenue in Global (2016-2021)
7.2.5 AstraZeneca (Europe) Key News
7.3 BioCryst Pharmaceuticals (U.S.)
7.3.1 BioCryst Pharmaceuticals (U.S.) Corporate Summary
7.3.2 BioCryst Pharmaceuticals (U.S.) Business Overview
7.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Major Product Offerings
7.3.4 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue in Global (2016-2021)
7.3.5 BioCryst Pharmaceuticals (U.S.) Key News
7.4 Novartis (Europe)
7.4.1 Novartis (Europe) Corporate Summary
7.4.2 Novartis (Europe) Business Overview
7.4.3 Novartis (Europe) Influenza Vaccination Major Product Offerings
7.4.4 Novartis (Europe) Influenza Vaccination Revenue in Global (2016-2021)
7.4.5 Novartis (Europe) Key News
7.5 DAIICHI SANKYO COMPANY (Asia Pacific)
7.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Corporate Summary
7.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
7.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Major Product Offerings
7.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue in Global (2016-2021)
7.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Key News
7.6 GlaxoSmithKline (Europe)
7.6.1 GlaxoSmithKline (Europe) Corporate Summary
7.6.2 GlaxoSmithKline (Europe) Business Overview
7.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Major Product Offerings
7.6.4 GlaxoSmithKline (Europe) Influenza Vaccination Revenue in Global (2016-2021)
7.6.5 GlaxoSmithKline (Europe) Key News
7.7 Hualan Biological Engineering (Asia Pacific)
7.7.1 Hualan Biological Engineering (Asia Pacific) Corporate Summary
7.7.2 Hualan Biological Engineering (Asia Pacific) Business Overview
7.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Major Product Offerings
7.4.4 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue in Global (2016-2021)
7.7.5 Hualan Biological Engineering (Asia Pacific) Key News
7.8 Mitsubishi Tanabe Pharma (Asia Pacific)
7.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Corporate Summary
7.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
7.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Major Product Offerings
7.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue in Global (2016-2021)
7.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Key News
7.9 F. Hoffmann-La Roche (Europe)
7.9.1 F. Hoffmann-La Roche (Europe) Corporate Summary
7.9.2 F. Hoffmann-La Roche (Europe) Business Overview
7.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Major Product Offerings
7.9.4 F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue in Global (2016-2021)
7.9.5 F. Hoffmann-La Roche (Europe) Key News
7.10 Sanofi (Europe)
7.10.1 Sanofi (Europe) Corporate Summary
7.10.2 Sanofi (Europe) Business Overview
7.10.3 Sanofi (Europe) Influenza Vaccination Major Product Offerings
7.10.4 Sanofi (Europe) Influenza Vaccination Revenue in Global (2016-2021)
7.10.5 Sanofi (Europe) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Influenza Vaccination Market Opportunities & Trends in Global Market
Table 2. Influenza Vaccination Market Drivers in Global Market
Table 3. Influenza Vaccination Market Restraints in Global Market
Table 4. Key Players of Influenza Vaccination in Global Market
Table 5. Top Influenza Vaccination Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Influenza Vaccination Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Influenza Vaccination Revenue Share by Companies, 2016-2021
Table 8. Global Companies Influenza Vaccination Product Type
Table 9. List of Global Tier 1 Influenza Vaccination Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza Vaccination Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type